Genetic and Tissue Engineering Approaches to Modeling the Mechanics of Human Heart Failure for Drug Discovery

Michael J. Greenberg, Neil J. Daily, Ann Wang, Michael K. Conway, Tetsuro Wakatsuki

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Abstract

Heart failure is the leading cause of death in the western world and as such, there is a great need for new therapies. Heart failure has a variable presentation in patients and a complex etiology; however, it is fundamentally a condition that affects the mechanics of cardiac contraction, preventing the heart from generating sufficient cardiac output under normal operating pressures. One of the major issues hindering the development of new therapies has been difficulties in developing appropriate in vitro model systems of human heart failure that recapitulate the essential changes in cardiac mechanics seen in the disease. Recent advances in stem cell technologies, genetic engineering, and tissue engineering have the potential to revolutionize our ability to model and study heart failure in vitro. Here, we review how these technologies are being applied to develop personalized models of heart failure and discover novel therapeutics.

Original languageEnglish
Article number120
JournalFrontiers in Cardiovascular Medicine
Volume5
DOIs
StatePublished - Sep 19 2018

Keywords

  • drug discovery
  • gene editing
  • heart failure
  • high-throughput screening
  • human induced pluripotent stem cells
  • length-tension relationship
  • rare heart disease
  • tissue engineering

Fingerprint

Dive into the research topics of 'Genetic and Tissue Engineering Approaches to Modeling the Mechanics of Human Heart Failure for Drug Discovery'. Together they form a unique fingerprint.

Cite this